Article
Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
24 Aug 2023
Abstract excerpt
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and one of the success stories in cancer therapeutics. Risk-directed therapy based on clinical, biologic and genetic features has played a significant role in this accomplishment. Despite the observed improvement in survival rates, leukemia remains one of the leading causes of cancer-related deaths. Implementation of next-generation genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
